Heaviest Female Gymnast, The False Uniqueness Effect Is Quizlet, Is Bernadette Peters Married Now, Blackfoot Name For Grandma, Articles S

lions led by donkeys for and against. To find better ways to treat patients. Sanjay Malhotra, Ph.D. Shivaani Kummar, M.D., FACP Shivaani Kummar, MD, FACP, is head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine, associate director for Clinical and Translational Research at the OHSU Knight Cancer Institute, and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics. Share on print. [] , 'Nm301' Als Shivaani Kummar Aim: Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of. The institute is involved with more than 400 clinical trials, including 113 early-phase trials. This conversation is with Shivaani Kummar, MD (professor, oncology), who joined the Stanford faculty in January 2015. What excites you about coming to work in the morning? OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. shivaani kummar ohsu email - howfenalcooksthat.com Division of Hematology and Medical Oncology Faculty and Staff - OHSU The unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. Hung, M.D. 2001-2023 OHSU. OHSU is an equal opportunity affirmative action institution. Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. Of that, $160 million was used for the Knight Cancer Research Building, which opened in 2018, and $40 million was used to build expanded capacity for clinical trial care in CHH2, which opened in 2019. Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Our ability to collaborate with academics and industries across the globe will be paramount to our success in developing new drugs for patients. This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted effects) may occur. Shivaani Kummar, MBBS, Portland, OR | Oncologist Their mission is clear: To give patients excellent care. She runs early phase clinical trials evaluating new treatments while ensuring highest standards of patient safety. Dr. And to train and inspire the next generation of doctors and scientists. Shivaani Kummar - .. - Oregon Health & Science University - ZoomInfo What is the importance of philanthropy to your work? Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. Articles Cited by Public access. Malhotras background is in chemical biology and drug development with a strong expertise in medicinal chemistry, including small molecule synthesis. Clinical trials are research studies that test how well new medicines or treatments work in people. A Ribas, T Medina, S Kummar, A Amin, A Kalbasi, JJ Drabick, M Barve, S Kummar, D Allen, A Monks, EC Polley, CD Hose, SP Ivy, IB Turkbey, Journal of Clinical Oncology 31 (18), 2296, Critical reviews in oncology/hematology 53 (3), 199-207, S Kummar, M Gutierrez, JH Doroshow, AJ Murgo, British journal of clinical pharmacology 62 (1), 15-26. Web Browser Accessibility, New early-phase clinical trial unit in the Center for Health and Healing Building 2 on South Waterfront centralizes care for cancer patients, provides more research opportunities, OHSU expands capacity for cancer clinical trials, OHSU Knight Cancer Institute: Understanding Cancer Clinical Trials, Expanding access to experimental cancer treatments in Oregon: Q&A with Shivaani Kummar, Severe respiratory illness season means boom times for OHSU virtual immediate care, OHSU leading effort to make cancer trials more inclusive, OHSU Child Life Specialist provides life-changing care to young patient living with chronic spinal condition, Making Hepatitis C care easier when treatment seems impossible. The Division of Hematology and Medical Oncology is headed by Shivaani Kummar, M.D., FACP and composed of many sections: Classical Hematology Community Oncology Hematologic Malignancies Palliative Care Portland VA Research Solid Tumor Stem Cell Transplantation Administration Section head Shivaani Kummar, M.D., FACP Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Dr. 2001-2023 OHSU. (OHSU/Joe Rojas-Burke), The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. 2001-2023 OHSU. Dr. Shivaani Kummar, MD, Medical Oncology Specialist - Portland, OR 9842741222, 9942641222, 9842724434 chinamanpaversscc@gmail.com. The provider is located at 3181 Sw Sam Jackson Park Rd Portland, Or 97239 and the phone number is (503) 314-7168 Which is Dr. Shivaani Kummar specialty? Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. , Bal0891 1 Expanding access to experimental cancer - Cancer Translated 2001-2022 Oregon Health & Science University. SHIVAANI KUMMAR, 207RX0202X - Medical Oncology Doctors & Physicians in PORTLAND, OR. In 2020, 470 Oregon residents from 28 counties consented to participate in clinical trial activities with the Knight Cancer Institute. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. She also leads the division of hematology & medical oncology in the OHSU School of Medicine. Faculty Spotlight - Shivaani Kummar, MD, FACP | Department of Medicine OHSU expands capacity for cancer clinical trials | OHSU News Privacy Notice: We use technologies, such as cookies, to customize content and advertising, to analyze traffic to the site and to provide a better overall experience to our users. The two will co-lead the institutes new Center for Experimental Therapeutics, uniting cutting-edge technologies with multidisciplinary preclinical and clinical investigators. Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute . Their partnership will be a perfect pairing.. Username or E-mail. The 13,000-square-foot early-phase research unit is located on the 12th floor of OHSUs Center for Health and Healing Building 2 on OHSUs South Waterfront campus. Learn more about clinical trials at the Knight Cancer Institute, The 13,000-square-foot early-phase research unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. Email: trials@ohsu.edu Call: 503-494-1080 Local: (503) 228-1730 | Toll Free: (800) 462-6608 Clinical Activity of the -Secretase Inhibitor PF-03084014 in Adults Home; NPI Lookup; Doctors; Medical Groups & Orgs; Taxonomy Codes; Lookup NPI Numbers from the NPI Registry . Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU Sort. Program Guide - ASCO Meeting Program Guide - American Society of At the end of the day, we need to develop better treatment for cancer patients and the only way to build that is through collaboration within OHSU and with other academic centers, biotech and pharma companies., Team science can be a buzz word. Shivaani Kummar Dr. Kummar was recently appointed as Division Chief of Hematology and Oncology, and co-Director of the Center for Experimental Therapeutics, at the Oregon Health and Science University in Portland, Oregon. NPI 1053612341 Dr. Shivaani Kummar in Portland - Address, Medicare Seventeen patients with desmoid tumors received PF-03084014 150 mg orally twice a day in 3-week cycles. . This philanthropy-fueled research revolution is already saving lives. S Kummar, R Kinders, L Rubinstein, RE Parchment, AJ Murgo, J Collins, Journal of Soil and Water Conservation 53 (3), 230-240. DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, S Kummar, R Kinders, ME Gutierrez, L Rubinstein, RE Parchment, Journal of clinical oncology 27 (16), 2705. Want to join the faculty at the Knight Cancer Institute? PHYSICIAN HELPLINE Phone: 1-866-742-4811 Fax: 650-320-9443 Monday - Friday, 8 a.m. - 5 p.m. Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. OHSU Knight Cancer Institute is a national leader in cancer research and training and well-known for its ability to turn cancer research discoveries into new cancer treatments. Within our Center for Experimental Therapeutics, Knight Cancer Institute, we have multiple ongoing projects trying to identify new ways to target cancer. A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, New England Journal of Medicine 378 (8), 731-739. Philanthropy will allow us to expand the number of ongoing projects, including those focusing on rare tumors, as well as take on more pre- and post-doctoral students to train the next generation of cancer researchers. Education & Training Oregon Health & Science University Fellowship, Hematology and Medical Oncology, 1995 - 1997 New York Presbyterian Hospital (Columbia Campus) Residency, Internal Medicine, 1990 - 1993 Harvard Medical School Class of 1989 OHSU is an equal opportunity affirmative action institution. . A Rajan, CA Carter, RJ Kelly, M Gutierrez, S Kummar, E Szabo, Clinical cancer research 18 (8), 2344-2351. The provider's speciality is Internal Medicine with a focus in Medical Oncology How many years of experience does Dr. Shivaani Kummar have? Web Browser Accessibility, An open-label, multicenter Phase I dose escalation study to characterize safety, tolerability, preliminary antitumor activity, pharmacokinetics and maximum tolerated dose of VIP152 (BAY 1251152) as monotherapy or combination therapy in subjects with advanced cancer. shivaani kummar ohsu email. Shivaani Kummar - Google Scholar Shivaani Kummar. She received her medical degree from Lady Hardinge Medical College and has been in practice for . Support the Abortion Care and Training Fund. Overall: 4.7 out of 5 Dr. Kummar specializes in the care and treatment of patients with cancer. Dr. Drukers vision for the field of translational oncology is similar to our vision of how to move discoveries from laboratories towardthe clinic. OHSU is an equal opportunity affirmative action institution. Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute, speaks with staff members on Aug. 23, 2021. February 17, 2023. condition, procedure, doctor name. edu h-index 8546 Citations 49 h-index 1996 2023 Research activity per year Overview Fingerprint Network Grants (5) Publications (174) Similar Profiles (1) If you made any changes in Pure these will be visible here soon. Administrative Coordinator, Karri Garaventa Dr. OHSU is an equal opportunity affirmative action institution. It is a privilege to be able to work in this field. shivaani kummar ohsu email - eachoneteachoneffi.com Where is Dr. Shivaani Kummar located? S Kummar, ME Gutierrez, ER Gardner, X Chen, WD Figg, M Zajac-Kaye, European journal of cancer 46 (2), 340-347, Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials, Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies, Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and LymphomasPhase I Trial of ABT-888 with Topotecan, Phase I study of single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumors, Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements, Compressing drug development timelines in oncology using phase'0'trials, Wee1 kinase as a target for cancer therapy, Using cereal grain winter cover crops to reduce groundwater nitrate contamination in the mid-Atlantic coastal plain, A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas, SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter StudySD-101 Combined with Pembrolizumab in Advanced Melanoma, Cediranib for metastatic alveolar soft part sarcoma, Primary non-Hodgkin's lymphoma of the liver, Drug development in oncology: classical cytotoxics and molecularly targeted agents, A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid TumorsPhase I Study of Olaparib with Cisplatin and Gemcitabine, Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell CancerAdenosine 2A Receptor Blockade as a Cancer Immunotherapy, Advances in using PARP inhibitors to treat cancer, Clinicopathologic Features of NonSmall-Cell Lung Cancer Harboring an, Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies, Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Visit thebilling andinsurancesection of our sitefor more information. Administrative Coordinator, Ingrid Studebaker All these new agents have shown promising anticancer activity in laboratory testing and are now being evaluated in patients. 23 () 'Oregon Health & Science University Knight Cancer Institute (OHSU)' BAL0891 1 . NPI Lookup NPI Database. Trisha Silbernagel, RN, BSN, early-phase clinical trial unit manager, checks equipment on Aug. 23, 2021. Accepting new patients These topic labels come from the works of this person. She currently practices at Oregon Health And Sciencs University Primary Care Clinic and is affiliated with Stanford Health Care. We also share information about your use of our site with our trusted social media, advertising and analytics partners. Notice of Privacy Practices By continuing you agree to the use of cookies. Combining PARP Inhibitor with Immunotherapy - Does the Promise of Preclinical Data Translate to Clinic? Shivaani Kummar M.D., FACP | Health care provider | OHSU I am humbled and inspired by the courage, grace and feeling of altruism that I find in each and every patient who chooses to participate in these trials. Patients and Methods. Bergan, R., Coussens, L., McWeeney, S., Spellman, P., Streeter, P., Winters-Stone, K., Bagby, G., Mori, M., Corless, C., Harrington, C., Hoatlin, M., Koop, D., Magun, B., Druker, B., Shannon, J. We have a number of clinical trials investigating promising new strategies to treat cancer. Dr. Shivaani Kummar, Oncologist - FindaTopDoc OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys. We are delighted she has chosen to join us, said Brian Druker, M.D., director of the OHSU Knight Cancer Institute. Stat4Onc Annual Symposium What sort of projects are you working on right now? OHSU HOSPITAL AND CLINICS - (Acute Care) 3181 SW SAM JACKSON PARK ROAD Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Cancer and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Blood Diseases, Cancer and Blood Disorders, Hematology and Oncology, Cancer, Cancer and Blood Disorders and Benign Blood Disorders, Cancer, Hematology Oncology and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Medical Oncology and Hematology, Cancer, Blood Diseases and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Bladder Cancer, Cancer, Hematology Oncology and Blood Cancers, Hospice and Palliative Care, Internal Medicine and Psychiatry, Hospice and Palliative Care and Palliative Care, Hospice and Palliative Care, Internal Medicine and Geriatrics, Sarah Lowry, D.N.P., ACNP-BC, AOCNP, ACHPN, Thomas G. DeLoughery, M.D., M.A.C.P., FAWM. We have a billion reasons why you should join us. Shivaani Kummar - Professor of Medicine - Stanford - LinkedIn Over the past six months, a multidisciplinary team has been coordinating patient experience, drug delivery, staffing schedules and equipment needed to support the range of clinical trials offered in the unit that span 14 different cancer disease groups. Keep me signed in. Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU MSK earns merit extension from NCI - The Cancer Letter Notice of Privacy Practices Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. 2001-2022 Oregon Health & Science University. Spray Foam Equipment and Chemicals. Password. Shivaani Kummar 1 2 , Apurva K Srivastava 3 , Tony Navas 3 4 , Fabiola Cecchi 5 6 , Young H Lee 5 7 , Donald P Bottaro 5 , Sook Ryun Park 1 8 , Khanh T Do 1 9 , Woondong Jeong 1 10 , Barry C Johnson 1 , Andrea R Voth 1 , Larry Rubinstein 11 , John J Wright 1 , Ralph E Parchment 3 , James H Doroshow 1 12 , Alice P Chen 13 Shivaani Kummar: STUDY00021194: A phase 1 study of SGN-CD228A in select advanced solid tumors: . Together they form a unique fingerprint. General Information Email: ohsufinfo@ohsu.edu, Mailing Address Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight. Shivaani Kummar Oregon Health & Science University In 2014, the state of Oregon supported the OHSU Knight Cancer Challenge by providing $200 million in bonding to support building cancer research and clinical trial capacity. 2001-2022 Oregon Health & Science University. shivaani kummar ohsu email . Together their goal is to find a cure for cancer. Affiliated Hospitals Medical Group Practices Practice Location 3181 Sw Sam Jackson Park Rd Portland, Oregon 97239-3011 Map and Directions Phone: (503) 314-7168 Office Hours: Monday - Friday: 8:00 AM - 5:00 PM Saturday - Sunday: Closed (h.c.), Ph.D., FAACR Director of CEDAR Sadik Esener, Ph.D. Director of precision oncology and SMMART Gordon Mills, M.D.,Ph.D. Dr. Shivaani Kummar, MD is a medical oncology specialist in Portland, OR. Verified email at ohsu.edu. Expanding scientific knowledge is a key mission of OHSU, Oregons only academic health center. Shivaani Kummar (Principal Investigator, PI), OHSU Mary Crowley Cancer Research, Montefiore Medical Center 4 1 . Four questions with Shivaani Kummar, MD, FACP | OHSU Foundation However, high costs, long development t Members receive periodic email communication about events, programming, news and funding opportunities. By using this website, we will assume that you agree to the terms and conditions of our privacy policy. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Its staff of physicians, nurses, pharmacists, data coordinators and clinical research coordinators are trained and experienced in caring for people participating in cancer clinical trials. Increasing (gender) diversity on a journal: a case study - Elsevier Connect Neoadjuvant nivolumab shows long-term benefit in NSCLC Primary Care Physicians Browse Primary Care Physiciansnear you Atlanta, GA Austin, TX Baltimore, MD Boston, MA Chicago, IL Dallas, TX Denver, CO Detroit, MI Houston, TX February 17, 2023 In Brief Edith Mitchell named enterprise vice president for cancer disparities at Jefferson SKCC Lisa M. Coussens, M.D. Dr. Kummar completed a residency at Emory University. Yourinsurancecompany will also be able to inform you of any copayments, coinsurance, or deductibles that will be your responsibility. She shares our urgency to better understand how research and drug development can help the patients who desperately need better treatments, today.. massachusetts vs washington state. Drukers approach to team science is incorporated throughout the institutes infrastructure. If you made any changes in Pure these will be visible here soon. The Division of Hematology and Medical Oncology is headed byShivaani Kummar, M.D., FACPand composed of many sections: Kathleen Beebe Shivaani Kummar, M.D., FACP, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's You can also correspond with Dr. Shivaani Kummar through mail at her mailing address at 3181 Sw Sam Jackson Park Rd, , Portland, Oregon - 97239-3011 (mailing address contact number . Administrative Coordinator, Felicia Feingersch Before scheduling your appointment, we recommend you contact yourinsurancecompany to verify that the OHSU Health location or provider you plan to visit is included in your network. The purpose of the study is to learn more about the study drug, VIP152, in combination with pembrolizumab in people with advanced or . He has the mindset and the clear vision to make that mindset a reality., Malhotra agrees: We speak the same language. CET membership is open to anyone at OHSU with an interest in advancing drug discovery and development. Most recently, he was the director for Stanford SRI Drug Discovery and Development Program, and he trained with Nobel laureate Herb Brown at Purdue University. Dive into the research topics where Shivaani Kummar is active. Tom Sellers named lead research officer at OHSU Knight Cancer Institute Title. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid BYLINE. She co-leads a team of 90 faculty members and along with her husband, Sanjay Malhotra, PhD, is focused on discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments. OHSU Knight Cancer Institute Archives - The Cancer Letter Vol.49 No.07. Dr. Shivaani Kummar - Medical Oncology, Portland OR OHSU HOSPITAL AND CLINICS: 380009: Provider Business Practice Location Address Details: Address: 3181 Sw Sam Jackson Park Rd, City: Portland . OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. shivaani kummar ohsu email. As an oncologist, Dr. Kummar manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Kummar and Malhotra who have a high school-aged daughter and middle school-aged son met while she was faculty at Yale University. A husband-wife team known for specializing in cancer drug development have joined the OHSU Knight Cancer Institute. (OHSU/Joe Rojas-Burke). These new agents include those targeting genetic changes (alterations in the DNA of the cancer cell), those that harness the immune system to work against the cancer, and others. Across OHSU, doctors and researchers are reimagining early disease detection. , 'Bal0891' 1 < < < - Claire Yoshida, M.S.N., A.C.N.S.-B.C., A.C.H.P.N. February 17, 2023 In Brief Edith Mitchell named enterprise vice president for cancer disparities at Jefferson SKCC scripps institution of oceanography graduate programs; rosemont seneca advisors website February 17, 2023. OHSU is an equal opportunity affirmative action institution. Dr. . shivaani kummar ohsu email - chinamanpavers.in , 'Bal0891' 1 Read more to learn about Shivaani Kummar, MBBS's background, education, and other specialties. Ashok Muralidaran, M.D., discusses how his passions inspire his work as a pediatric cardiac surgeon. Our ability to move these projects forward and to take on new projects is limited by the available resources. Share on email. Office 3181 SW Sam Jackson Park Rd Portland, OR 97239 Phone+1 503-280-1223 Is this information wrong? SHIVAANI KUMMAR, Medical Oncology PORTLAND, OR - NPI 1053612341 what was bolivar's ultimate goal? (Getty Images), Communications Manager, OHSU Knight Cancer Institute, Husband-wife team from Stanford University tapped to lead two cancer programs at OHSU, OHSU leading effort to make cancer trials more inclusive, Making Hepatitis C care easier when treatment seems impossible, Pill for skin disease also curbs excessive drinking, OHSU clinical trial tests exercise for multiple sclerosis treatment. Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. Harnessing the predictive power of preclinical models for oncology drug Stock and Other Ownership Interests: PathomIQ, Arxeon Therapeutics (I) Consulting or Advisory Role: Seattle Genetics, Bayer, Boehringer Ingelheim, Mundipharma EDO GmbH, Harbour BioMed, SpringWorks Therapeutics, Gilead Sciences, Mirati Therapeutics, EcoR1 Capital, Cadila Pharmaceuticals (I), Oxford BioTherapeutics. The units team of physicians, nurses, pharmacists, data coordinators and clinical research coordinators are trained and experienced in caring for people participating in cancer clinical trials. . My clinical work is focused on conducting early phase clinical trials, enrolling and caring for patients on these trials. S Kummar, J Ji, R Morgan, HJ Lenz, SL Puhalla, CP Belani, DR Gandara, Clinical Cancer Research 18 (6), 1726-1734.